Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Frequently asked questions
What sector does Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) operate in?
Inspira Technologies Oxy B.H.N. Ltd. Warrant belongs to the Healthcare sector and operates in the industry.
What is Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) current stock price?
As of the latest data, Inspira Technologies Oxy B.H.N. Ltd. Warrant stock price is $0.01, with a previous close of $0.01.
What is Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) current market capitalization?
Inspira Technologies Oxy B.H.N. Ltd. Warrant market cap is approximately 359.49 thousand.
What is Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) Earnings Per Share (EPS)?
The trailing EPS is -$3.67.
Does Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) pay dividends?
No. Inspira Technologies Oxy B.H.N. Ltd. Warrant does not pay a dividend.
What is Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) beta (volatility) score?
Inspira Technologies Oxy B.H.N. Ltd. Warrant has a beta of 2.162, indicating very high volatility compared to the market.